{"disease":{"id":"irritability","name":"irritability","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":4},"drugs":{"marketed":[{"drug_id":"dmae","indication_name":"irritability","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dmae 1549","generic_name":"DMAE","company_name":"Professional Complementary Health Formulas","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":16,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04632082","title":"Telepsychoeducation for the Prevention of Emotional Distress in Professionals and Students From Essential Services in the Context of COVID-19","phase":"NA","overall_status":"UNKNOWN","enrollment_count":2200,"lead_sponsor_name":"Hospital de Clinicas de Porto Alegre","has_results":false},{"nct_id":"NCT07424404","title":"A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Karuna Therapeutics, Inc., a Bristol Myers Squibb company","has_results":false},{"nct_id":"NCT05523895","title":"Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum Disorder","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":237,"lead_sponsor_name":"ACADIA Pharmaceuticals Inc.","has_results":true},{"nct_id":"NCT05555615","title":"Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum Disorder","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":209,"lead_sponsor_name":"ACADIA Pharmaceuticals Inc.","has_results":true},{"nct_id":"NCT02531893","title":"Psychological Treatments for Youth With Severe Irritability.","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"National Institute of Mental Health (NIMH)","has_results":false},{"nct_id":"NCT07284745","title":"A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":176,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT07285798","title":"A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum Disorder","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":176,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT03238118","title":"Attention Bias Modification, Attention Control and Psychoeducation for Irritability in Children and Adolescents","phase":"NA","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"Hospital de Clinicas de Porto Alegre","has_results":false},{"nct_id":"NCT06871488","title":"Predictors of Improvements in Irritability and Aggression in Children With ADHD Treated With CNS Stimulants","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":136,"lead_sponsor_name":"Milton S. Hershey Medical Center","has_results":false},{"nct_id":"NCT04174365","title":"Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":119,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT01965184","title":"Cognitive-Behavioral Therapy for Disruptive Behavior in Children and Adolescents","phase":"NA","overall_status":"COMPLETED","enrollment_count":101,"lead_sponsor_name":"Yale University","has_results":false},{"nct_id":"NCT04258839","title":"Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder for Subjects That Have Completed Participation in 331-201-00148","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":95,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT07424781","title":"Fluoxetine on Emotional Experience (FLEX) Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT06484088","title":"Study Brain Mechanisms of Frustration With Magnetoencephalography in Healthy Volunteers","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"National Institute of Mental Health (NIMH)","has_results":false},{"nct_id":"NCT03464773","title":"Pain and Irritability in Non-Verbal Children","phase":"NA","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT03854019","title":"Evaluating the Efficacy of Dextromethorphan/Quinidine in Treating Irritability in Huntington's Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"The University of Texas Health Science Center, Houston","has_results":true},{"nct_id":"NCT04619862","title":"Efficacy of Gabapentin in Treating Pain in Children With SNI (Gabapentin Trial)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":5,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT05733390","title":"A Study of JZP541 in Adults With Irritability Associated With Autism Spectrum Disorder","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Jazz Pharmaceuticals","has_results":false}],"total":18},"guidelines":[],"source":"Drug Landscape verified database"}